Worth reading
59In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
7429
¥ millionWording
Conditional
How definitive the wording is.Results for this period
Full year1 March 2025–28 February 2026ConsolidatedJapanese GAAPNet Sales128,794¥ millionYear on year +3.5%Progress 81.0%
Operating profit31,154¥ millionYear on year -2.7%Progress 81.7%
Ordinary income32,621¥ millionYear on year -8.0%Progress 85.3%
Net income attributable to owners of the parent19,048¥ millionYear on year -19.4%Progress 68.5%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥109.33
Operating Margin24.2
Financial position at period-end
Total assets197,302¥ million
of which net assets 139,961 ¥ millionEquity ratio 66.0%vs. prior year-end +3.2pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+31,191
Investment-3,300
Financials-15,520
Net change+12,371
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥74,341 million
Segment revenueSemiconductor and FPD Equipment Business ¥127,593 million (YoY +3.5%), Life Sciences Business ¥1,201 million (YoY +11.8%)
Segment profitSemiconductor and FPD Equipment Business ¥32,003 million (YoY -2.9%), Life Sciences Business ¥13 million (YoY -89.1%)
Regional sales¥9,951 million, ¥31,845 million, ¥35,767 million, ¥6,657 million, ¥32,874 million, ¥11,697 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥159,021 million (YoY +23.5%)
Operating profit¥38,112 million (YoY +22.3%)
Ordinary income¥38,241 million (YoY +17.2%)
Net income¥27,809 million (YoY +46.0%)
Annual Dividend Forecast¥17 → ¥20
Payout ratioFiscal year ended February 2026 15.5 % / FY2027/2 forecast 12.5 %
Shareholder Return PolicyThe Company’s basic policy is to maintain stable dividends while securing retained earnings necessary for future business development and strengthening its management base, and to return profits after comprehensively considering earnings trends, financial conditions and other factors. Numerical target: Not disclosed.
Factors Behind Changes in Business Performance
Revenue increased on higher demand from customers in Taiwan, while selling, general and administrative expenses rose due to the impact of the consolidation period for an overseas subsidiary brought into the scope of consolidation in the previous fiscal year, as well as amortization of goodwill related to that subsidiary. Net income attributable to owners of the parent declined following the recognition of ¥7,429 million in litigation loss provision expense.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 No見積りの変更 Yes修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name None
Material subsequent eventsOn 13 March 2026, a jury verdict was rendered by a U.S. District Court accepting the claims of Kawasaki Heavy Industries,Ltd., with damages provisionally set at US$48 million. The Company stated that it would pursue legal measures, including post-trial motions and appeals.
Impairment lossNot applicable.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥12 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥194 million, Provision for litigation loss ¥7,429 million
Depreciation and amortization¥3,129 million
Orders received and order backlogOrders received ¥113,371 million / Order backlog ¥55,408 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for institutional investors and analysts)
Issued Shares at Period-End176,400,000
Treasury Shares at Period-End2,968,260
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 March 2025–28 February 2026 |
| Net Sales | ¥128,794 million (YoY +3.5%) |
| Operating profit | ¥31,154 million (YoY -2.7%) |
| Ordinary income | ¥32,621 million (YoY -8.0%) |
| Profit attributable to owners of the parent | ¥19,048 million (YoY -19.4%) |
| Net income per share | ¥109.33 |
| Operating Margin | 24.2 |
| Equity ratio | End of the current fiscal period 66 / End of previous period 62.8 |
| Total assets | ¥197,302 million |
| Net assets | ¥139,961 million |
| Cash flows from operating activities | ¥31,191 million |
| Cash flows from investing activities | ¥-3,300 million |
| Cash flows from financing activities | ¥-15,520 million |
| Cash and cash equivalents at end of period | ¥74,341 million |
| Full-year earnings forecast | Net Sales ¥159,021 million (YoY +23.5%) / Operating profit ¥38,112 million (YoY +22.3%) / Ordinary income ¥38,241 million (YoY +17.2%) / Net income ¥27,809 million (YoY +46.0%) |
| Annual Dividend Forecast | ¥17 → ¥20 |
| Payout ratio | Fiscal year ended February 2026 15.5 % / FY2027/2 forecast 12.5 % |
| Shareholder Return Policy | The Company’s basic policy is to maintain stable dividends while securing retained earnings necessary for future business development and strengthening its management base, and to return profits after comprehensively considering earnings trends, financial conditions and other factors. Numerical target: Not disclosed. |
| Segment revenue | Semiconductor and FPD Equipment Business ¥127,593 million (YoY +3.5%), Life Sciences Business ¥1,201 million (YoY +11.8%) |
| Segment profit | Semiconductor and FPD Equipment Business ¥32,003 million (YoY -2.9%), Life Sciences Business ¥13 million (YoY -89.1%) |
| Regional sales | ¥9,951 million, ¥31,845 million, ¥35,767 million, ¥6,657 million, ¥32,874 million, ¥11,697 million |
| Orders received and order backlog | Orders received ¥113,371 million / Order backlog ¥55,408 million |
| Depreciation and amortization | ¥3,129 million |
| Impairment loss | Not applicable. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥12 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥194 million, Provision for litigation loss ¥7,429 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate Yes / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Material subsequent events | On 13 March 2026, a jury verdict was rendered by a U.S. District Court accepting the claims of Kawasaki Heavy Industries,Ltd., with damages provisionally set at US$48 million. The Company stated that it would pursue legal measures, including post-trial motions and appeals. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 176,400,000 |
| Treasury Shares at Period-End | 2,968,260 |
| Factors Behind Changes in Business Performance | Revenue increased on higher demand from customers in Taiwan, while selling, general and administrative expenses rose due to the impact of the consolidation period for an overseas subsidiary brought into the scope of consolidation in the previous fiscal year, as well as amortization of goodwill related to that subsidiary. Net income attributable to owners of the parent declined following the recognition of ¥7,429 million in litigation loss provision expense. |
Items this document does not state (1)
Revision to Earnings Forecast
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased on higher demand from customers in Taiwan, while selling, general and administrative expenses rose due to the impact of the consolidation period for an overseas subsidiary brought into the scope of consolidation in the previous fiscal year, as well as amortization of goodwill related to that subsidiary. The Company also recognized ¥7,429 million in litigation loss provision expense as an extraordinary loss.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.